Cimicoxib for the Treatment of Major Depression (SECIM)

NCT00510822 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

169

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depression

Interventions

DRUG: Cimicoxib
DRUG: Placebo

Sponsor

Affectis Pharmaceuticals AG

Collaborators

[object Object]